Oral administration of losartan influences aminopeptidase activity in the frontal cortex
- 31 July 2000
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 10 (4) , 279-282
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Purification, Characterization, and Cloning of a Cytosolic Aspartyl AminopeptidaseJournal of Biological Chemistry, 1998
- Renal aminopeptidase activities in animal models of hypertensionRegulatory Peptides, 1997
- Bovine brain pyroglutamyl aminopeptidase (type-1): Purification and characterisation of a neuropeptide-inactivating peptidaseThe International Journal of Biochemistry & Cell Biology, 1996
- Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in ratsEuropean Journal of Pharmacology, 1996
- The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase APeptides, 1996
- Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functionsRegulatory Peptides, 1995
- Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in miceNature, 1995
- Formation of des-Asp-angiotensin I in the Hypothalamic Extract of Normo- and Hypertensive RatsBlood Pressure, 1994
- Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrierEuropean Journal of Pharmacology, 1992